Literature DB >> 12114222

Growth hormone in growth hormone deficiency.

Paul Saenger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12114222      PMCID： PMC1123623          DOI： 10.1136/bmj.325.7355.58

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

Review 1.  Four decades of growth hormone therapy for short children: what have we achieved?

Authors:  H J Guyda
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

2.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

3.  Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study.

Authors:  M B Ranke; D A Price; K Albertsson-Wikland; M Maes; A Lindberg
Journal:  Horm Res       Date:  1997

4.  Mutations in PROP1 cause familial combined pituitary hormone deficiency.

Authors:  W Wu; J D Cogan; R W Pfäffle; J S Dasen; H Frisch; S M O'Connell; S E Flynn; M R Brown; P E Mullis; J S Parks; J A Phillips; M G Rosenfeld
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature.

Authors:  Gudrun A Rappold; Maki Fukami; Beate Niesler; Simone Schiller; Walter Zumkeller; Markus Bettendorf; Udo Heinrich; Elpis Vlachopapadoupoulou; Thomas Reinehr; Kazumichi Onigata; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

6.  Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety.

Authors:  Pinchas Cohen; George M Bright; Alan D Rogol; Anne-Marie Kappelgaard; Ron G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

Review 7.  Turner's syndrome.

Authors:  M B Ranke; P Saenger
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

8.  Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment.

Authors:  M Tauber; P Moulin; C Pienkowski; B Jouret; P Rochiccioli
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

9.  Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group.

Authors:  S L Blethen; J Baptista; J Kuntze; T Foley; S LaFranchi; A Johanson
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

10.  Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population based registry.

Authors:  Jean-Claude Carel; Emmanuel Ecosse; Marc Nicolino; Maïté Tauber; Juliane Leger; Sylvie Cabrol; Irène Bastié-Sigeac; Jean-Louis Chaussain; Joël Coste
Journal:  BMJ       Date:  2002-07-13
View more
  1 in total

1.  Growth hormone in growth hormone deficiency. Ignore the evidence and keep going wrong.

Authors:  Jean-Claude Carel; Emmanuel Ecosse; Joël Coste
Journal:  BMJ       Date:  2002-11-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.